Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short-term Investments Total Current Liabilities Total Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

CorMedix (CRMD) Total Non-Current Liabilities (2016 - 2021)

CorMedix has reported Total Non-Current Liabilities over the past 6 years, most recently at $6.0 million for Q4 2021.

Quarterly results put Total Non-Current Liabilities at $6.0 million for Q4 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was $6.0 million (changed N/A YoY), and the annual figure for FY2021 was $6.0 million, changed.
Total Non-Current Liabilities reached $6.0 million in Q4 2021 per CRMD's latest filing, up from $3.9 million in the prior quarter.
Across five years, Total Non-Current Liabilities topped out at $6.0 million in Q4 2021 and bottomed at $3.9 million in Q2 2017.